Company intelligence / Profile preview
Shenzhou Cell Engineering Co., Ltd.
Beijing, Beijing Shi, Chinabloomberg.com ↗
- Ownership
- Private
- Development stage
- Phase 1
01
Overview
Shenzhou Cell Engineering has developed a rich product pipeline spanning oncology, autoimmune disorders, genetic diseases and preventive vaccines. It has achieved approvals for biosimilars such as adalimumab for Crohn’s disease and advanced vaccine candidates into late-stage clinical trials. Its SCTB35 bispecific antibody targeting CD20xCD3 entered Phase I trials in relapsed/refractory B-cell non-Hodgkin lymphoma in early/mid‑2024. The company leverages robust proprietary technology platforms covering both upstream cell engineering/bioprocessing and downstream product development.
- Therapeutic areas
- OncologyRare DiseasesImmunologyGastroenterologyInfectious Diseases
- Modalities
- Monoclonal antibodies (mAbs)Therapeutic vaccinesMultivalent vaccinesBiosimilarsBispecific antibodies
- Industry
- Biotech
02
Drug pipeline
3 assets2 more assets in the full pipeline.
Request access →Beyond the preview
Go deeper on Shenzhou Cell Engineering Co., Ltd..
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Shenzhou Cell Engineering Co., Ltd..